Cipla Ltd.

Cipla’s wholly owned subsidiary -- Cipla (EU) has completed acquisition of additional 15.10% in the Cipla Maroc SA, Morocco, (JV Co.), from The Pharmaceutical Institute (PHI) for a consideration of Moroccan Dirham 81.1 million on November 24, 2023. 

Accordingly, Cipla EU will now hold 75.10% stake in the JV Co. and balance 24.90% stake will be held by Societe Marocaine De Cooperation Pharmaceutique (CooperPharma).

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients.